Opposing effects of interferon-α and interferon-γ on the expression of major histocompatibility complex class I chain-related A in tumors

Cancer Science

Volumn 99, Issue 6, 2008, Pages 1279-1286

  Zhang, Cai ^a   Niu, Jiafeng ^a   Zhang, Jianhua ^a   Wang, Yiping ^a   Zhou, Zhixia ^a   Zhang, Jian ^a   Tian, Zhigang ^a  

^a SHANDONG UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; GAMMA INTERFERON; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MATRIX METALLOPROTEINASE; NATURAL KILLER CELL RECEPTOR NKG2D;

ANTIGEN EXPRESSION; ARTICLE; CONTROLLED STUDY; CYTOLYSIS; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; IMMUNE RESPONSE; NATURAL KILLER CELL; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DEGRADATION; PROTEIN TARGETING; TRANSCRIPTION REGULATION; TUMOR CELL; TUMOR IMMUNITY;

ANTINEOPLASTIC AGENTS; BLOTTING, WESTERN; CELLS, CULTURED; CYTOTOXICITY, IMMUNOLOGIC; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; INTERFERON TYPE I, RECOMBINANT; INTERFERON-GAMMA, RECOMBINANT; KILLER CELLS, NATURAL; LUCIFERASES; METALLOPROTEASES; NEOPLASMS; PROMOTER REGIONS (GENETICS); RECEPTORS, IMMUNOLOGIC; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TRANSFECTION;

EID: 43549085090     PISSN: 13479032     EISSN: 13497006     Source Type: Journal    
DOI: 10.1111/j.1349-7006.2008.00791.x     Document Type: Article

References (33)

1. Cerwenka A, Lanier LL. Natural killer cells, viruses and cancer. Nat Rev Immunol 2001; 1: 41-9.
2. Smyth MJ, Hayakawa Y, Takeda K, Yagita H. New aspects of natural-killer cell surveillance and therapy of cancer. Nat Rev Cancer 2002; 2: 850-61.
3. Hallett WH, Murphy WJ. Natural killer cells: Biology and clinical use in cancer therapy. Cell Mol Immunol 2004; 1: 12-21.
4. Raulet DH. Roles of the NKG2D immunoreceptor and its ligands. Nat Rev Immunol 2003; 3: 781-90.
5. Watzl C. The NKG2D receptor and its ligands - recognition beyond the 'missing self'? Microbes Infection 2003; 5: 31-7.
6. Cerwenka A, Lanier LL. NKG2D ligands: Unconventional MHC class I-like molecules exploited by viruses and cancer. Tissue Antigen 2003; 61: 335-43.
7. Mistry AR, O'Callaghan CA. Regulation of ligands for the activating receptor NKG2D. Immunology 2007; 121: 439-47.
8. Zhang C, Zhang J, Sun R, Feng J, Wei H, Tian Z. Opposing effect of IFNγ and IFNα on expression of NKG2 receptors: Negative regulation of IFNγ on NK cells. Int Immunopharmacol 2005; 5: 1057-67.
9. Dong Z, Zhang C, Wei H, Sun R, Tian Z. Impaired NK cell cytotoxicity by high level of interferon-γ in concanavalin A-induced hepatitis. Can J Physiol Pharmacol 2005; 83: 1045-53.
10. Zhang C, Tian Z, Hou G, Zhang J, Wang J, Sun R. Influence of HLA class I molecules expression on tumor cell resistance to NK lysis and the IFN-γ regulatory effect. Zhonghua Zhong Liu ZA Zhi 2001; 23: 369-72.
11. Pende D, Accame L, Pareti L et al. The susceptibility to natural killer cell-mediated lysis of HLA class I-positive melanomas reflects the expression of insufficient amounts of different HLA class I alleles. Eur J Immunol 1998; 28: 2384-94.
12. Dunn GP, Koebel CM, Schreiber RD. Interferons, immunity and cancer immunoediting. Nat Rev Immunol 2006; 6: 836-48.
13. Groh V, Wu J, Yee C, Spies T. Tumour-derived soluble MIC ligands impair expression of NKG2D and T-cell activation. Nature 2002; 419: 734-8.
14. Jinushi M, Takehara T, Tatsumi T et al. Impairment of natural killer cell and dendritic cell functions by the soluble form of MHC class I-related chain A in advanced human hepatocellular carcinomas. J Hepatol 2005; 43: 1013-20.
15. Märten A, von Lilienfeld-Toal M, Büchler MW, Schmidt J. Soluble MIC is elevated in the serum of patients with pancreatic carcinoma diminishing γδ T cell cytotoxicity. Int J Cancer 2006; 119: 2359-65.
16. Salih HR, Rammensee HG, Steinle A. Cutting edge: Down-regulation of MICA on human tumors by proteolytic shedding. J Immunol 2002; 169: 4098-102.
17. Demaria S, Bushkin Y. Soluble HLA proteins with bound peptides are released from the cell surface by the membrane metalloproteinase. Human Immunol 2000; 61: 1332-8.
18. Haynes LD, Bushkin Y, Love RB, Burlingham WJ. Interferon-γ drives the metalloproteinase-dependent cleavage of HLA class I soluble forms from primary human bronchial epithelial cells. Human Immunol 2002; 63: 893-901.
19. Gasser S, Raulet DH. The DNA damage response arouses the immune system. Cancer Res 2006; 66: 3959-62.
20. Jinushi M, Takehara T, Kanto T et al. Critical role of MHC class I-related chain A and B expression on IFNα-stimulated dendritic cells in NK cell activation: Impairment in chronic hepatitis C infection. J Immunol 2003; 170: 1249-56.
21. Jinushi M, Takehara T, Tatsumi T et al. Autocrine/paracrine IL-15 that is required for type I IFN-mediated dendritic cell expression of MHC class I-related chain A and B is impaired in hepatitis C virus infection. J Immunol 2003; 171: 5423-9.
22. Bui JD, Carayannopoulos LN, Lanier LL, Yokoyama WM, Schreiber RD. IFN-dependent downregulation of the NKG2D ligand H60 on tumors. J Immunol 2006; 176: 905-13.
23. Venkataraman GM, Suciu D, Groh V, Boss JM, Spies T. Promoter region architecture and transcriptional regulation of the genes for the MHC class I-related chain A and B ligands of NKG2D. J Immunol 2007; 178: 961-9.
24. Rodríguez-Rodero S, González S, Rodrigo L et al. Transcriptional regulation of MICA and MICB: A novel polymorphism in MICB promoter alters transcriptional regulation by Sp1. Eur J Immunol 2007; 37: 1938-53.
25. Pende D, Rivera P, Marcenaro S et al. Major histocompatability complex class I-related chain A and UL16-binding protein expression on tumor cell lines of different histiotypes: Analysis of tumor susceptibility to NKG2D-dependent natural killer cell cytotoxicity. Cancer Res 2002; 62: 6178-86.
26. Boehm U, Klamp T, Groot M, Howard C. Cellular responses to interferon-γ. Annu Rev Immunol 1997; 15: 749-95.
27. Malmberg KJ, Levitsky V, Norell H et al. IFN-γ protects short-term ovarian carcinoma cell lines from CTL lysis via a CD94/NKG2A-dependent mechanism. J Clin Invest 2002; 110: 1515-23.
28. Ota T, Takeda K, Akiba H et al. IFN-γ-mediated negative feedback regulation of NKT-cell function by CD94/NKG2. Blood 2005; 106: 184-92.
29. + Tregs. J Clin Invest 2006; 116: 2434-41.
30. Sawitzki B, Kingsley CI, Oliveira V, Karim M, Herber M, Wood KJ. IFN-γ production by alloantigen-reactive regulatory T cells is important for their regulatory function in vivo. J Exp Med 2005; 201: 1925-35.
31. + type 1 T regulatory subsets through IFN-γ-secreting Th1 cells. J Immunol 2006; 177: 3606-14.
32. Wood KJ, Sawitzki B. Interferon gamma: A crucial role in the function of induced regulatory T cells in vivo. Trends Immunol 2006; 27: 183-7.
33. Yang YG, Wang H, Asavaroengchai W, Dey BR. Role of interferon-γ in GVHD and GVL. Cell Mol Immunol 2005; 2: 323-9.